Harbert Fund Advisors, Inc.
- SEC CIK
- 0001616659
- Latest filing
- Aug 17, 2026
The latest 13F from Harbert Fund Advisors, Inc. covers Q2 2026 (filed Aug 17, 2026) and reports no long positions. Livermore has 23 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 0
- Added
- 0
- Reduced
- 0
- Sold out
- 2
- Est. −$3.03M
Top 5 holdings
Share of this quarter's portfolio value
This filing reports no long positions.
Biggest buys
New and added positions, by estimated amount bought
None this quarter.
Largest weight increases
New and added positions, by percentage points of the portfolio gained
None this quarter.
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $0
- −$3.03M (−100.0%) vs. prior quarter
- Positions
- 0
- −2 vs. prior quarter
- Top 10 concentration
- –
- Top 10 as share of value
- Turnover
- 0.0%
- Q2 2026, one quarter
- Average holding period
- –
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $216.3M (Q4 2021)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 17, 2026 | 0 | $0 | – | vs. Q1 2026 | SEC |
| Q1 2026 | May 14, 2026 | 2 | $3.03M | INVETACT | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 13, 2026 | 2 | $3.49M | INVETACT | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 13, 2025 | 12 | $15.3M | LQDAFRNMINVE | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 14, 2025 | 20 | $33.3M | CHYMLQDAFRNM | vs. Q1 2025 | SEC |
| Q1 2025 | May 14, 2025 | 54 | $86.2M | AMZNLQDAMSFT | vs. Q4 2024 | SEC |
| Q4 2024 | Feb 13, 2025 | 58 | $115.0M | PENNAMZNMSFT | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 14, 2024 | 75 | $124.1M | PENNTBCHAMZN | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 14, 2024 | 89 | $124.4M | PENNAMZNMSFT | vs. Q1 2024 | SEC |
| Q1 2024 | May 15, 2024 | 81 | $145.3M | TBCHAMZNMSFT | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 14, 2024 | 70 | $145.9M | ENZBINFUAMZN | vs. Q3 2023 | SEC |
| Q3 2023 | Jan 26, 2024Amended | 45 | $140.3M | AGSENZBVSEC | vs. Q2 2023 | SECSEC |
| Q2 2023 | Aug 14, 2023 | 42 | $155.9M | ENZBVSECARAY | vs. Q1 2023 | SEC |
| Q1 2023 | May 12, 2023 | 44 | $140.2M | ENZBAGSSTRM | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 13, 2023 | 45 | $116.0M | MNTVSTRMENZB | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 14, 2022 | 43 | $125.3M | ENZBGBLIINVE | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 12, 2022 | 41 | $132.6M | GBLIMNTVENZB | vs. Q1 2022 | SEC |
| Q1 2022 | May 16, 2022 | 36 | $193.5M | GBLIENZBMNTV | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 14, 2022 | 37 | $216.3M | INVEGBLIENZB | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 12, 2021 | 30 | $193.1M | GBLIENZBTBCH | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 16, 2021 | 32 | $179.2M | GBLIENZBTBCH | vs. Q1 2021 | SEC |
| Q1 2021 | May 17, 2021 | 24 | $148.4M | GBLIENZBTBCH | – | SEC |
13D and 13G filings
Companies where Harbert Fund Advisors, Inc. reports owning 5% or more on Schedule 13D or 13G, and its latest filings.
Current stakes of 5% or more
Harbert Fund Advisors, Inc. does not currently report owning 5% or more of any company.
Latest filings
8 filings on file made by Harbert Fund Advisors, Inc. or listing it as a reporting person, newest first.
| Company | Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|---|
| TACTTransact Technologies Inc | Sep 24, 20259:54 PM ET | Harbert Discovery Fund, LPand 6 others | 13D/A | 4.30%430.0K shares | −1.10 ppfrom 5.40%Below 5% | Sep 22, 2025 | SEC |
| TACTTransact Technologies Inc | Sep 4, 20259:07 PM ET | Harbert Discovery Fund, LPand 6 others | 13D/A | 5.40%540.1K shares | – | Sep 2, 2025 | SEC |
| STRMStreamline Health Solutions Inc. | Aug 14, 20259:28 PM ET | Harbert Discovery Fund, LPand 6 others | 13D/A | 0.00%0 shares | −7.80 ppfrom 7.80%Below 5% | Aug 12, 2025 | SEC |
| ENZBEnzo Biochem Inc | Jun 25, 20256:00 PM ET | Harbert Discovery Fund, LPand 8 others | 13D/A | 9.87%5.18M shares | – | Jun 23, 2025 | SEC |
| GBLIGlobal Indemnity Group, LLC | Oct 28, 2022 | Harbert Fund Advisors, Inc. | 13D/AOld format | – | – | – | SEC |
| GBLIGlobal Indemnity Group, LLC | Jan 6, 2022 | Harbert Fund Advisors, Inc. | 13D/AOld format | – | – | – | SEC |
| GBLIGlobal Indemnity Group, LLC | Aug 12, 2021 | Harbert Fund Advisors, Inc. | 13D/AOld format | – | – | – | SEC |
| GBLIGlobal Indemnity Group, LLC | May 19, 2021 | Harbert Fund Advisors, Inc. | 13D/AOld format | – | – | – | SEC |